Get the Stockscreener App
7.975
4.80%
0.365
Electrocore Inc stock is traded at $7.975, with a volume of 77,603.
It is up +4.80% in the last 24 hours and up +43.69% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$7.61
Open:
$7.63
24h Volume:
77,603
Relative Volume:
1.29
Market Cap:
$63.77M
Revenue:
$29.84M
Net Income/Loss:
$-14.16M
P/E Ratio:
-4.4426
EPS:
-1.7951
Net Cash Flow:
$-7.97M
1W Performance:
+9.55%
1M Performance:
+43.69%
6M Performance:
+61.93%
1Y Performance:
-46.58%
1-Day Range:
$7.5435
$8.165
1-Week Range:
$6.44
$8.165
52-Week Range:
$4.16
$15.68
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
7.975 | 60.85M | 29.84M | -14.16M | -7.97M | -1.7951 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
electroCore, Inc. (ECOR) Could Announce Losses: Understand the Pattern Before Q4 Results - Bitget
electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Finviz
ECOR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
electroCore (ECOR) Expected to Announce Quarterly Earnings on Wednesday - Defense World
electroCore, Inc. (NASDAQ:ECOR) Given Average Rating of "Hold" by Analysts - MarketBeat
CEO Change: Is electroCore Inc stock overvalued or fairly priced2025 Market Overview & Growth Focused Entry Point Reports - baoquankhu1.vn
ECOR SEC FilingsElectrocore 10-K, 10-Q, 8-K Forms - Stock Titan
Downgrade Watch: Is electroCore Inc stock a value trapJuly 2025 Reactions & Low Drawdown Momentum Ideas - baoquankhu1.vn
electroCore (NASDAQ:ECOR) Shares Down 2.1%Here's Why - MarketBeat
Market Recap: Is electroCore Inc a stock for growth or value investors2025 Major Catalysts & Expert-Curated Trade Recommendations - baoquankhu1.vn
Winners Losers: What are the future prospects of OneSpan IncWeekly Earnings Recap & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
electroCore (ECOR) Stock Analysis Report | Financials & Insights - Benzinga España
Aug Sentiment: What is the target price for JUNS stock2025 Top Gainers & Safe Entry Trade Reports - baoquankhu1.vn
Will electroCore Inc. benefit from rate cutsEarnings Growth Report & High Accuracy Buy Signal Tips - mfd.ru
Aug Macro: Will electroCore Inc outperform during market ralliesGap Down & Verified Short-Term Plans - baoquankhu1.vn
Is electroCore Inc.’s ROIC above industry averageJuly 2025 Action & Long Hold Capital Preservation Tips - mfd.ru
Published on: 2026-02-13 06:48:45 - baoquankhu1.vn
Bearish Setup: Should value investors consider electroCore IncJuly 2025 Sector Moves & Low Risk High Reward Ideas - baoquankhu1.vn
Brokerages Set electroCore, Inc. (NASDAQ:ECOR) PT at $22.00 - Defense World
Brookline Capital Acquisition Predicts electroCore FY2025 Earnings - Defense World
electroCore (NASDAQ:ECOR) Upgraded at Brookline Capital Management - Defense World
Will electroCore Inc outperform during market ralliesWeekly Stock Report & High Accuracy Investment Signals - baoquankhu1.vn
Setup Watch: Is electroCore Inc being accumulated by smart moneyJuly 2025 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
electroCore (NASDAQ:ECOR) Stock Rating Lowered by Zacks Research - MarketBeat
What’s the RSI of electroCore Inc. stockLayoff News & Low Drawdown Trading Strategies - mfd.ru
Analysts Set Expectations for electroCore FY2025 Earnings - Defense World
electroCore FY2025 EPS Forecast Increased by HC Wainwright - MarketBeat
ElectroCore expects FY 2025 revenue between $31.8M and $32M - MSN
HC Wainwright Comments on electroCore FY2030 Earnings - Defense World
HC Wainwright Estimates electroCore FY2030 Earnings - MarketBeat
electroCore (NASDAQ:ECOR) Given New $18.00 Price Target at HC Wainwright - Defense World
H.C. Wainwright lowers electroCore stock price target to $18 on higher expenses By Investing.com - Investing.com South Africa
H.C. Wainwright lowers electroCore stock price target to $18 on higher expenses - Investing.com Nigeria
HC Wainwright Has Lowered Expectations for electroCore (NASDAQ:ECOR) Stock Price - MarketBeat
electroCore's (ECOR) Price Target Lowered by HC Wainwright & Co. | ECOR Stock News - GuruFocus
Head to Head Contrast: Akebia Therapeutics (NASDAQ:AKBA) and electroCore (NASDAQ:ECOR) - Defense World
Digital Migraine Treatment Devices Market to Reach USD 298.71 - openPR.com
electroCore (ECOR) Partners with Acacia Clinics for PTSD Treatme - GuruFocus
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder ('PTSD”) - manilatimes.net
Acacia Clinics and Vagus Nerve Society Conduct Study Using - GlobeNewswire
New PTSD study tests non-invasive nerve device alongside standard care - Stock Titan
ElectroCore Announces Record Preliminary 2025 Revenue Guidance - TipRanks
electroCore reports 26% revenue growth for 2025 By Investing.com - Investing.com Canada
ECOR Ends 2025 with Lower Cash Reserves - GuruFocus
electroCore reports 26% revenue growth for 2025 - Investing.com
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8-$32.0 Million - The Manila Times
ElectroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million - marketscreener.com
electroCore Provides Preliminary Full-Year 2025 Business - GlobeNewswire
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million - Sahm
Financial Survey: Telomir Pharmaceuticals (NASDAQ:TELO) versus electroCore (NASDAQ:ECOR) - Defense World
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - Intellectia AI
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):